Healthcare products maker Novartis AG (
) on Wednesday announced it would buy the rest of eye care products
maker Alcon, Inc. (
) that it doesn't already own for around $12.9 billion.
Novartis will pay a total of $168 per share for ACL, which will
become the second largest division within Novartis. The company
will also roll is CIBA VISION and certain Novartis ophthalmic
medicines into Alcon.
Novartis shares rose $4.42, or +7.9%, in premarket trading
The Bottom Line
Shares of Novartis (
) have a 3.08% dividend yield, based on last night's closing stock
price of $55.83. The stock has technical support in the $52 price
area. If the shares can build on the early pop, we see overhead
resistance around the all-time highs of $61 a share.
Novartis AG (
) is not recommended at this time, holding a Dividend.com DARS™
Rating of 3.4 out of 5 stars.
Be sure to visit our complete recommended list of the
Best Dividend Stocks
, as well as a detailed explanation of
our ratings system here
Created by Dividend.com